Mapping and understanding alveolar cells in smokers with COPD
Official title: Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
Run by Centre Hospitalier Intercommunal Creteil · NCT05227547 · Data updated 2026-11-12
This study is trying to understand how certain lung cells behave in smokers with COPD compared to non-smokers to learn more about how smoking affects lung repair.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 186 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 4 sites (Créteil and 3 other locations) |
| Status | Recruiting |
| Started | October 5, 2022 |
| Main results expected | October 5, 2030 |
| Study ends | October 5, 2030 |
| Registry record updated | September 2, 2025 |
| Trial ID | NCT05227547 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who are undergoing lung resection surgery for cancer or suspected cancer and are smokers with or without COPD.
✕Probably not a fit
Patients with chronic autoimmune diseases, those undergoing neo-adjuvant chemotherapy, or individuals who are pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the regenerative abilities of mesenchymal cells in the alveolar type 2 cells of patients undergoing thoracic surgery for suspected cancer. It focuses on smokers with and without chronic obstructive pulmonary disease (COPD) and compares them to non-smokers. The research aims to uncover the mechanisms behind the depletion of alveolar progenitor cells and their role in the pathophysiology of COPD. By analyzing the interactions between different cell populations in the alveolar stem cell niche, the study seeks to provide insights into lung repair processes affected by smoking and COPD.
Why it matters
Potential benefit: If successful, this study could lead to new therapeutic strategies for enhancing lung repair in patients with COPD.
How similar studies have gone: While similar studies have explored cell interactions in lung diseases, this specific approach to mapping alveolar cells in smokers with COPD is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 2. Patient undergoing lung resection surgery (lobectomy, pneumonectomy, segmentectomy) for cancer or suspected cancer 3. Acceptance to participate in the protocol 4. Affiliated to a social security plan Exclusion Criteria: 1. Chronic autoimmune disease 2. Patient under guardianship or curators 3. Neo-adjuvant chemotherapy 4. History of thoracic radiotherapy 5. Pregnant woman 6. Minor patient 7. Person not able to consent 8. Person deprived of liberty
Where it's running
-
Rousseau-Bussac
Créteil, France Recruiting -
Hopital Cochin
Paris, France Active not recruiting -
Hegp
Paris, France Active not recruiting -
Hopital Tenon
Paris, France Active not recruiting
Study contacts
- Study coordinator: JUNG Camille, MD
- Email: camille.jung@chiccreteil.fr
- Phone: 0145175000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flutter therapy added to chest physiotherapy after CABG in COPD patients
This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.
-
TPB-based cadence exercise and breathing training for COPD patients
A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.
-
See how dynamic chest X-rays relate to COPD patterns and progression risk
This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.
-
Personalized mobile app warnings to reduce COPD flares
A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.
-
CLEAR model to predict when people with severe COPD can be taken off ventilatory support
This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.
-
Long-term safety of Tozorakimab in COPD patients with prior exacerbations
This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.